Document type: | Patente |
Inventor(s): | SALDANHA, Luiz Leonardo; BOSQUEIRO, Anne Lígia Dokkedal; BOSQUEIRO, José Roberto; HENRIQUES, Nathalia Aparecida De Paula Camaforte; VAREDA, Priscilla Maria Ponce; VILEGAS, Wagner; QUEIROZ, Emerson Ferreira; MARCOURT, Laurence; WOLFENDER, Jean-Luc |
Applicant: | Universidade Estadual Paulista (UNESP) ; Université de Genève |
Deposit date: | June 2016, 28 |
INPI register: | |
IPC: | A61K 31/7028 A61P 3/10 A61P 3/00 |
(EN) The present Invention relates to the use of cyanoglucoside according to formula (I) and formulations thereof in the prevention and/or treatment of diabetes and/or metabolic syndrome; wherein R1, R2 and R3 are independently selected from an optionally substituted mono- or di- saccharide, -O-R4, -O- C(O)-R4 and halogen such as CI, F or Br, wherein R4 is selected from H, alkyl such as methyl, as well as tautomers, geometrical isomers, optically active forms, pharmaceutically acceptable salts and pharmaceutically active derivative thereof.
FAPESP's process: | 09/52237-9 - Standardized herbal medicines for the treatment of chronic diseases |
Grantee: | Wagner Vilegas |
Principal Investigator: | Wagner Vilegas |
Institution: | Universidade Estadual Paulista (UNESP). Campus Experimental do Litoral Paulista. Instituto de Biociências (IB-CLP) |
Support Opportunities: | BIOTA-FAPESP Program - Thematic Grants |